MAPT and Alzheimer disease: Although the presence of neurofibrillary tangles in tau inclusions is a critical biomarker for the pathological diagnosis of AD patients, AD is considered as a secondary tauopathy, due to the combined deposits consisting of intracellular NFTs and of extracellular amyloid-β (Aβ) plaques [62,63,64].